InvestorsHub Logo
Post# of 251732
Next 10
Followers 827
Posts 119581
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 228801

Thursday, 05/07/2020 5:06:53 PM

Thursday, May 07, 2020 5:06:53 PM

Post# of 251732
RVNC 1Q20 results—3/31/20 cash=$511M:

https://investors.revance.com/news-releases/news-release-details/revance-reports-first-quarter-2020-financial-results-provides

2020 operating cash burn is expected to be at the low end of the prior guidance range of $220-230M due to one-quarter delay (to 3Q20) in the US launch of Teoxane’s dermal fillers.

MYL’s decision whether to opt in for the Botox-biosimilar program is expected by the end of May.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.